Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care
- Sponsor
- Medical University of Graz
- Study ID
- NCT06327828
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Semi-automated computer-aided treatment (Digital Thyroid, DigiThy) — DEVICESemi-automated computer-aided treatment based on a mathematical model
- Usual care — PROCEDUREGuiding methimazole therapy based on the treating physician's decision
Study Details
The goal of this clinical trial is to compare two methods of guiding methimazole therapy in patients with Graves' disease: methimazole dose adjustments based on a new semi-automated computer-guided treatment (based on a mathematical model) or based on the treating physician's decision (i.e. usual care). The main question it aims to answer is whether semi-automated computer-guided treatment is not inferior to usual care in terms of safety, the time it takes to achieve euthyroidism and the methimazole dose required.
Key Dates
- Start date
- Sep 1, 2024
- Status verified
- May 2024
- Primary completion
- Oct 1, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Semi-automated computer-aided treatmentTreatment based on the dosing suggestions by a mathematical algorithm and cross-checked by the treating physician
- Active Comparator: Usual careTreatment based on the dosing suggestions by the treating physician
Primary Outcome Measure
The primary aim is to compare semi-automated computer-guided treatment with usual care in terms of their performance indices [ Time Frame: 18 months ]
Central Contacts
- Verena Theiler-Schwetz, MD, PhD++4331638582383
- Stefan Pilz, MD, PhD
Related Studies
- Personalized Treatment in Thyroid DisordersRecruiting · Johns Hopkins University · Baltimore, Maryland
- Preoperative Corticosteroids in Autoimmune Thyroid DiseasePHASE4 · Recruiting · Indiana University · Indianapolis, Indiana
- The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid DysfunctionRecruiting · Walter Reed National Military Medical Center · Bethesda, Maryland
- Study of BHV-1300 in Graves' DiseasePHASE1 · Recruiting · Biohaven Therapeutics Ltd. · South Gate, California